Clinical Trials Logo

Clinical Trial Summary

The primary objectives of this study are: 1. Determine the percentage of patients whose surgical plan would change with FET-PET/MRI compared to MRI alone. 2. Determine the percentage of patients who have residual tumor after surgery detected with FET-PET/MRI. A secondary objective of this study is: 1) Perform preliminary correlations between the pre- and post-surgical metabolic tumor volumes measured with FET-PET/MRI to progression free survival.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03451123
Study type Interventional
Source University of Alabama at Birmingham
Contact
Status Terminated
Phase Early Phase 1
Start date April 23, 2018
Completion date August 29, 2023

See also
  Status Clinical Trial Phase
Completed NCT02947373 - Pilot Study of Safety and Toxicity of Acquiring Hyperpolarized Carbon-13 Imaging in Children With Brain Tumors Phase 1